| Nov 4 |
Empower 2024 Delivers Groundbreaking Insights and Innovation to Achieve Data-Driven Healthcare
|
| Nov 1 |
Stocks that hedge funds moved from long to short in August - Jefferies
|
| Nov 1 |
Johnson & Johnson MedTech concludes enrolment for OMNY-AF trial pilot phase
|
| Nov 1 |
J&J Medtech CIO Larry Jones resigns
|
| Oct 31 |
The Zacks Analyst Blog Highlights Amazon.com, Johnson & Johnson, Boston Scientific and Armanino Foods of Distinction
|
| Oct 31 |
Psoriasis biosimilars and pricing changes herald treatment paradigm disruptions
|
| Oct 30 |
Top Stock Reports for Amazon.com, Johnson & Johnson and Boston Scientific
|
| Oct 29 |
J&J and Lilly both unveil IL-23 inhibitor efficacy in Crohn’s disease
|
| Oct 29 |
J&J to seek FDA approval after small-bore Impella heart pump hits trial goal
|
| Oct 28 |
Global Psychedelic Drugs Market Expected To Reach $10.2B By 2028 Amid Growing Mental Health Crises
|
